Oncoclínicas faces civil suit seeking joint liability with Anbima over IPO shareholder compensation

Oncoclínicas disclosed a civil lawsuit seeking joint liability with Anbima and compensation for shareholders who bought shares in its IPO or secondary market. The claim appears to allege misrepresentation or omission in offering documents, though specifics are unconfirmed. This marks a legal challenge to the company's capital markets conduct, potentially affecting investor sentiment and regulatory scrutiny.